[1] 中华医学会儿科学分会心血管学组, 中华儿科杂志编辑委员会.川崎病冠状动脉病变的临床处理建议(2020年修订版)[J].中华儿科杂志, 2020, 58(9):718-724. [2] FUKAZAWA R, KOBAYASHI J, AYUSAWA M, et al.JCS/JSCS 2020 Guideline on Diagnosis and Management of Cardiovascular Sequelae in Kawasaki Disease[J].Circ J, 2020, 84(8): 1348-1407. [3] CHAUDHARY H, NAMEIRAKPAM J, KUMRAH R, et al.Biomarkers for Kawasaki disease: Clinical utility and the challenges ahead[J].Front Pediatr, 2019(7):242. [4] KURT C, ALTUNCEKI C Y A.Contribution of erythrocyte sedimentation rate to predict disease severity and outcome in COVID-19 patients[J].Can J Infect Dis Med Microbiol,2022(2022):6510952. [5] ANDRESDOTTIR M B, SIGFUSSON N, SIGVALDASON H, et al. Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: The Reykjavik Study[J].Am J Epidemiol, 2003,158(9):844-851. [6] KAWAI Y, MATSUYAMA H, KORENAGA Y, et al.Preoperative erythrocyte sedimentation rate is an independent prognostic factor in Japanese patients with localized clear cell renal cell carcinoma[J].Urol Int, 2009,83(3):306-310. [7] DIMA A, OPRIS D, JURCUT C, et al. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?[J].Lupus, 2016,25(11):1173-1179. [8] 黄国英.川崎病诊断和治疗面临的挑战[J].中华儿科杂志, 2022, 60(1):3-5. [9] MCCRINDLE B W, ROWLEY A H, NEWBURGER J W, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: A scientific statement for health professionals from the American Heart Association[J].Circulation, 2017, 135(17): e927-e999. [10] NAGATA S. Causes of Kawasaki disease-from past to present[J].Front Pediatr, 2019(7):18. [11] LEE J J Y, LIN E, WIDDIFIELD J, et al. The long-term cardiac and noncardiac prognosis of Kawasaki disease: A systematic review[J].Pediatrics, 2022, 149(3): e2021052567. [12] DANIELS L M, TOSH P K, FIALA J A, et al. Extremely elevated erythrocyte sedimentation rates: Associations with patients' diagnoses, demographic characteristics, and comorbidities[J].Mayo Clin Proc, 2017, 92(11): 1636-1643. [13] TALSTAD I, HAUGEN H F.The relationship between the erythrocyte sedimentation rate (ESR) and plasma proteins in clinical materials and models[J].Scand J Clin Lab Invest, 1979, 39(6): 519-524. [14] YOSHIZAWA H, NOGAMI K, MATSUMOTO T, et al.Dynamic evaluation of hemostasis in the acute phase of Kawasaki disease using comprehensive coagulation functional assays[J].Thromb Res, 2019(174):76-83. [15] WENG H, PENG Y, PEI Q, et al. Decreased serum Annexin A1 levels in Kawasaki disease with coronary artery aneurysm[J].Pediatr Res, 2021, 89(3): 569-573. [16] ERIKSSEN G, LIESTØL K, BJØRNHOLT J V, et al.Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality[J].Eur Heart J, 2000, 21(19): 1614-1620. [17] DANESH J, COLLINS R, PETO R, et al. Haematocrit, viscosity, erythrocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease[J].Eur Heart J, 2000, 21(7): 515-520. [18] XIU-YU S, JIA-YU H, QIANG H, et al. Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis[J].J Clin Lab Anal, 2010, 24(6): 385-388. [19] ZANDSTRA J, van de GEER A, TANCK M W T, et al.Biomarkers for the discrimination of acute Kawasaki disease from infections in childhood[J].Front Pediatr, 2020(8):355. [20] CHANG L S, LIN Y J, YAN J H, et al. Neutrophil-to-lymphocyte ratio and scoring system for predicting coronary artery lesions of Kawasaki disease[J].BMC Pediatr, 2020,20(1):398. |